Meningioma

A rare, mostly benign, primary tumor of the meninges (arachnoid cap cells), usually located in the supratentorial compartment, commonly appearing in the sixth and seventh decade of life, clinically silent in most cases or causing hyperostosis close to the tumor and resulting in focal bulging and localized pain in less than 10% of cases. Additional features may include headache, seizures, gradual personality changes (apathy and dementia), anosmia, impaired vision, exophthalmos, hearing loss, ataxia, dysmetria, hypotonia, nystagmus, and rarely spontaneous bleeding.

Prostate cancer

A cancer of the prostate.

Total: 21

(per page)

PMID (PMCID)
30077749	MALE
	Fluciclovine, Anti-1-Amino-3-[18F]-Fluorocyclobutane-1-Carboxylic Acid: A Novel Radiotracer for Meningioma.
	Nguyen QD, Amato R, Riascos R, Ballester L, Tandon N, Blanco A, Esquenazi Y. World Neurosurg. 2018;119:132-136.
	In each of these cases, the meningioma was incidentally found during surveillance using PET imaging in patients with prostate cancer.
27046016	MALE
	Acute Progression of Recurrent Meningioma during Luteinizing Hormone-Releasing Hormone Agonist Treatment for Prostate Cancer.
	Tsutsui T, Miyashita K, Sabit H, Fukui I, Hayashi Y, Mizokami A, Ikeda H, Nagatani H, Nakada M. World Neurosurg. 2016;91:670.e1-6.
	Acute Progression of Recurrent Meningioma during Luteinizing Hormone-Releasing Hormone Agonist Treatment for Prostate Cancer.
25899597	MALE
	Incidental Meningioma Detected on 18F-Fluoride With PET/CT During Initial Staging for Prostate Cancer.
	Teo TY, Menda Y, McNeely P, Kahn D, Graham M. Clin Nucl Med. 2015;40(7):596-7.
	Incidental Meningioma Detected on 18F-Fluoride With PET/CT During Initial Staging for Prostate Cancer.
24201100 (4533482)	MALE
	Progression of intracranial meningioma during luteinizing hormone-releasing hormone agonist treatment for prostate cancer: case report.
	Anda T, Honda M, Ishihara T, Kamei T. Neurol Med Chir (Tokyo). 2014;54(4):327-30.
	Progression of intracranial meningioma during luteinizing hormone-releasing hormone agonist treatment for prostate cancer: case report.
24201100 (4533482)	MALE
	Progression of intracranial meningioma during luteinizing hormone-releasing hormone agonist treatment for prostate cancer: case report.
	Anda T, Honda M, Ishihara T, Kamei T. Neurol Med Chir (Tokyo). 2014;54(4):327-30.
	The authors describe a male patient who developed a large intracranial meningioma during the hormone therapy for pre-existing prostate cancer.
23698517	MALE
	Incidental 11C-choline PET/CT brain uptake due to meningioma in a patient studied for prostate cancer: correlation with MRI and imaging fusion.
	Bertagna F, Bosio G, Pinelli L, Treglia G, Giubbini R. Clin Nucl Med. 2013;38(11):e435-7.
	Incidental 11C-choline PET/CT brain uptake due to meningioma in a patient studied for prostate cancer: correlation with MRI and imaging fusion.
21872130	MALE
	Intracranial dural metastatic prostate cancer can mimic meningioma: a report of two cases.
	Chen TY, Lee HJ, Wu TC, Tsui YK, Wu TC. Clin Imaging. 2011;35(5):391-4.
	Intracranial dural metastatic prostate cancer can mimic meningioma: a report of two cases.
22000836	MALE
	Metastatic prostate adenocarcinoma invading an atypical meningioma.
	Mitchell RA, Dimou J, Tsui A, Kavar B. J Clin Neurosci. 2011;18(12):1723-5.
	To our knowledge, this is the first report of prostate cancer metastasising to an atypical meningioma.
22233858	MALE
	[Dural metastasis as the first manifestation of prostate cancer].
	Alcala-Cerra G, Gutierrez-Paternina JJ, Nino-Hernandez LM, Sabogal-Barrios R, Moscote-Salazar LR, Suarez-Jaramillo K. An Sist Sanit Navar. 2011;34(3):513-7.
	Metastases of prostate cancer to intracranial meninges are rare and often confused with meningiomas or chronic subdural hematomas.
20033754	MIXED_SAMPLE	Middle Aged
	Parafalcine lesions in the cancer patient: diagnostic dilemma--meningioma or metastatic lesion?
	Mumert ML, Jensen EM, Jensen R. J Neurooncol. 2010;99(1):135-9.
	The first patient with known metastatic prostate cancer had imaging studies suggestive of a parafalcine meningioma, but after surgical resection the lesion was found to be histologically consistent with metastatic disease.
12893358	MALE	Middle Aged
	Luteinizing hormone-releasing hormone agonists and meningioma: a treatment dilemma.
	Lee KL, Terris MK. Urology. 2003;62(2):351.
	The relative contraindication of hormonal therapy for patients with prostate cancer and a history of meningioma has not been widely emphasized.
10210920	MALE
	Bilateral sphenoid wing metastases of prostate cancer presenting with extensive brain edema.
	Lindsberg PJ, Tatlisumak T, Tienari J, Brander A. Eur J Neurol. 1999;6(3):363-6.
	Intracranial metastases of prostate cancer may have a predilection site at the sphenoid wing, and can mimic a skull base meningioma.
8274090	MALE
	[Cerebral metastasis from prostatic neoplasm simulating meningioma. Report of a case].
	Oliveira MA, Araujo JF, Balbo RJ. Arq Neuropsiquiatr. 1993;51(2):251-2.
	However, there is an important number of reports on a variety of other lesions simulating meningioma, including the prostate cancer.
8274090	MALE
	[Cerebral metastasis from prostatic neoplasm simulating meningioma. Report of a case].
	Oliveira MA, Araujo JF, Balbo RJ. Arq Neuropsiquiatr. 1993;51(2):251-2.
	The authors describe one additional patient with prostate cancer who at presentation had clinical and radiographic signs suggesting meningioma.
3785633	MALE	Middle Aged
	Cranial metastases from prostate cancer simulating meningioma: report of two cases and review of the literature.
	Lippman SM, Buzaid AC, Iacono RP, Steinbronn DV, Stanisic TH, Rennels MA, Yang PJ, Garewal HS, Ahmann FR. Neurosurgery. 1986;19(5):820-3.
	From the data gathered, we conclude that metastatic prostate cancer should be considered in the differential diagnosis of elderly males who present with characteristic clinical and radiological features of meningioma and that the classical description of meningioma is not specific.
3785633	MALE	Middle Aged
	Cranial metastases from prostate cancer simulating meningioma: report of two cases and review of the literature.
	Lippman SM, Buzaid AC, Iacono RP, Steinbronn DV, Stanisic TH, Rennels MA, Yang PJ, Garewal HS, Ahmann FR. Neurosurgery. 1986;19(5):820-3.
	Cranial metastases from prostate cancer simulating meningioma: report of two cases and review of the literature.
3785633	MALE	Middle Aged
	Cranial metastases from prostate cancer simulating meningioma: report of two cases and review of the literature.
	Lippman SM, Buzaid AC, Iacono RP, Steinbronn DV, Stanisic TH, Rennels MA, Yang PJ, Garewal HS, Ahmann FR. Neurosurgery. 1986;19(5):820-3.
	From the data gathered, we conclude that metastatic prostate cancer should be considered in the differential diagnosis of elderly males who present with characteristic clinical and radiological features of meningioma and that the classical description of meningioma is not specific.
6646385	MALE	Middle Aged
	Triple fossa metastasis of prostate cancer.
	Kwee IL, Nakada T, St John JN. Neurosurgery. 1983;13(5):584-6.
	The radiological appearance of prostate cancer metastasis to the central nervous system often mimics meningioma.
6646385	MALE	Middle Aged
	Triple fossa metastasis of prostate cancer.
	Kwee IL, Nakada T, St John JN. Neurosurgery. 1983;13(5):584-6.
	The bony change of prostate cancer metastasis resembles the hyperostosis of meningioma because of its blastic rather than lytic nature.
6646385	MALE	Middle Aged
	Triple fossa metastasis of prostate cancer.
	Kwee IL, Nakada T, St John JN. Neurosurgery. 1983;13(5):584-6.
	We report a case demonstrating the CT findings typical for a triple fossa meningioma caused by prostate cancer metastasis.